Therapy with amlodipine besylate/benazepril HCl provides superior control in patients with severe systolic hypertension.

被引：0
|
作者：
Nwose, O [1 ]
Jean-Louis, L [1 ]
Schofield, L [1 ]
Purkayastha, D [1 ]
Baron, M [1 ]
机构：
[1] Novartis Pharmaceut Corp, E Hanover, NJ USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2003年 / 43卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
84
引用
收藏
页码：1034 / 1034
页数：1
相关论文
共 50 条
  • [21] Author Correction: Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension
    Lei-Ke Zhang
    Yuan Sun
    Haolong Zeng
    Qingxing Wang
    Xiaming Jiang
    Wei-Juan Shang
    Yan Wu
    Shufen Li
    Yu-Lan Zhang
    Zhao-Nian Hao
    Hongbo Chen
    Runming Jin
    Wei Liu
    Hao Li
    Ke Peng
    Gengfu Xiao
    Cell Discovery, 7
  • [22] 24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertension
    Lacourciere, Y.
    Crikelair, N.
    Glazer, R. D.
    Yen, J.
    Calhoun, D. A.
    JOURNAL OF HUMAN HYPERTENSION, 2011, 25 (10) : 615 - 622
  • [23] 24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertension
    Y Lacourcière
    N Crikelair
    R D Glazer
    J Yen
    D A Calhoun
    Journal of Human Hypertension, 2011, 25 : 615 - 622
  • [24] EFFECT OF BASELINE SYSTOLIC BLOOD PRESSURE ON RESPONSE TO TRIPLE COMBINATION AMLODIPINE/VALSARTAN/HYDROCHLOROTHIAZIDE IN PATIENTS WITH MODERATE-TO-SEVERE HYPERTENSION
    Lacourciere, Y.
    Glazer, R.
    Crikelair, N.
    Yen, J.
    Calhoun, D.
    JOURNAL OF HYPERTENSION, 2009, 27 : S119 - S119
  • [25] ALISKIREN MONOTHERAPY PROVIDES SUPERIOR BLOOD PRESSURE (BP) REDUCTION TO HYDROCHLOROTHIAZIDE (HCT) MONOTHERAPY WITH NO EVIDENCE OF PARADOXICAL BP RISES IN PATIENTS WITH HYPERTENSION.
    Schmieder, R. E.
    Zhang, J.
    Hsu, H.
    Botha, J.
    Keefe, D. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S72 - S72
  • [26] Effective blood-pressure control with valsartan/HCTZ combination therapy in patients with moderate to severe systolic hypertension: The Valor trial
    Lacoursiere, Y
    Hebert, D
    Assouline, L
    Rehel, B
    Khder, Y
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 115A - 115A
  • [27] Effective blood-pressure control with valsartan/HCTZ combination therapy in patients with moderate to severe systolic hypertension: The Valor trial
    Lacoursiere, Y
    Hebert, D
    Assouline, L
    Rehel, B
    Khder, Y
    JOURNAL OF HYPERTENSION, 2004, 22 : S301 - S301
  • [28] SYSTOLIC BLOOD PRESSURE REDUCTION DURING ANTIHYPERTENSIVE THERAPY AND THE PREDICTION OF NEW-ONSET ATRIAL FIBRILLATION IN PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION. THE LIFE STUDY
    Larstorp, A. C. K.
    Wachtell, K.
    Olsen, M. H.
    Jern, S.
    Okin, P. M.
    Devereux, R. B.
    Ibsen, H.
    Dahlof, B.
    Kjeldsen, S. E.
    JOURNAL OF HYPERTENSION, 2009, 27 : S317 - S317
  • [29] TWENTY-FOUR HOUR AMBULATORY BP CONTROL OF THERAPY WITH AMLODIPINE/VALSARTAN/HCTZ TRIPLE COMBINATION COMPARED TO DUAL THERAPY IN PATIENTS WITH MODERATE TO SEVERE HYPERTENSION
    Lacourciere, Y.
    Glazer, R. D.
    Yen, J.
    Calhoun, D. A.
    JOURNAL OF HYPERTENSION, 2009, 27 : S271 - S271
  • [30] Utility of low doses of single-pill amlodipine besylate/atorvastatin calcium in the control of concomitant hypertension and dyslipidemia: Results of a pooled analysis of 2572 patients
    Feldman, R. D.
    Da Silva, P. Marques
    Blank, R. C.
    Erdine, S.
    Shi, H.
    Moller, R. A.
    Schou, I. M.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 : 436 - 436
12345